- Home
- QGEN vs BIRK Comparison
QGEN vs BIRK Comparison
Compare QGEN & BIRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QGEN
- BIRK
- Stock Information
- Founded
- QGEN 1986
- BIRK 1774
- Country
- QGEN Netherlands
- BIRK United Kingdom
- Employees
- QGEN N/A
- BIRK N/A
- Industry
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- BIRK
- Sector
- QGEN Health Care
- BIRK
- Exchange
- QGEN Nasdaq
- BIRK Nasdaq
- Market Cap
- QGEN 9.1B
- BIRK 8.8B
- IPO Year
- QGEN 1996
- BIRK 2023
- Fundamental
- Price
- QGEN $48.08
- BIRK $47.51
- Analyst Decision
- QGEN Buy
- BIRK Strong Buy
- Analyst Count
- QGEN 8
- BIRK 10
- Target Price
- QGEN $50.68
- BIRK $69.00
- AVG Volume (30 Days)
- QGEN 1.3M
- BIRK 2.0M
- Earning Date
- QGEN 08-05-2025
- BIRK 08-28-2025
- Dividend Yield
- QGEN 3.14%
- BIRK N/A
- EPS Growth
- QGEN N/A
- BIRK 152.58
- EPS
- QGEN 0.42
- BIRK 1.45
- Revenue
- QGEN $2,002,874,000.00
- BIRK $2,114,754,647.00
- Revenue This Year
- QGEN $6.36
- BIRK $19.19
- Revenue Next Year
- QGEN $6.18
- BIRK $15.95
- P/E Ratio
- QGEN $115.46
- BIRK $32.86
- Revenue Growth
- QGEN 3.31
- BIRK 19.89
- 52 Week Low
- QGEN $37.63
- BIRK $40.56
- 52 Week High
- QGEN $48.90
- BIRK $64.78
- Technical
- Relative Strength Index (RSI)
- QGEN 59.71
- BIRK 29.21
- Support Level
- QGEN $47.25
- BIRK $47.75
- Resistance Level
- QGEN $48.90
- BIRK $48.91
- Average True Range (ATR)
- QGEN 0.81
- BIRK 1.23
- MACD
- QGEN -0.12
- BIRK -0.22
- Stochastic Oscillator
- QGEN 68.98
- BIRK 2.41
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).
About BIRK Birkenstock Holding plc
Birkenstock Holding PLC is a company that manufactures and sells footbed-based products, including sandals, closed-toe silhouettes, and other products, such as skincare and accessories, for everyday, leisure, and work. It sells its products through two main channels: business-to-business (B2B) which comprises sales made to established third-party store networks, and direct-to-consumer (DTC) which comprises sales made on globally owned online stores through the Birkenstock.com domain and sales made in Birkenstock retail stores. The company's reportable segments are based on its regional hubs and include: the Americas which is also its key revenue-generating segment; Europe; and Australia, Japan, India, China, and the United Arab Emirates (APMA).